Contrast CT/MRI · EUS Biopsy · Whipple Procedure · Systemic Therapy
At HYGEIA Healthcare, our hepatobiliary-pancreatic teams provide comprehensive, multi-disciplinary care for pancreatic cancer — from precise imaging and tissue diagnosis through pancreaticoduodenectomy, systemic therapy, and pain and nutrition support. Our specialists build a personalized plan for every patient.
Our treatment program covers the full pathway:
Pancreaticoduodenectomy performed by high-volume hepatobiliary-pancreatic surgeons, with meticulous vascular reconstruction and enhanced-recovery protocols that shorten hospital stay for patients traveling from abroad.
Conventional and metronomic chemotherapy protocols administered by experienced oncology nurses in comfortable infusion suites. We use evidence-based regimens tailored to your specific cancer type and stage, with comprehensive side-effect management.
Precision medicine using drugs that specifically target the molecular drivers of your cancer. Genetic and molecular profiling guides treatment selection, maximizing efficacy while sparing healthy cells.
Harnessing the body's own immune system to fight cancer through checkpoint inhibitors and other immunotherapeutic approaches, used alone or alongside standard treatments.
Advanced radiation techniques including stereotactic body radiotherapy (SBRT) deliver precise doses to tumors while protecting surrounding healthy tissue. Suitable for early-stage or unresectable disease.
As a major oncology group, HYGEIA participates in clinical trials for innovative cancer therapies. Eligible patients may access cutting-edge treatments before they become widely available.
For borderline-resectable and advanced disease, modern combination regimens can shrink tumors before surgery or control progression. Our team selects the regimen based on performance status, liver function and molecular findings.
Pancreatic cancer is often silent until late. For individuals with unexplained weight loss, new diabetes, jaundice or a family history, contrast-enhanced CT combined with the CA19-9 marker is the most reliable first assessment.
PET-CT imaging combined with CT- or EBUS-guided biopsy provides accurate tumor staging, ensuring the treatment plan matches the true extent of disease.
Tissue and liquid biopsy testing for driver mutations and PD-L1 expression identifies which targeted or immune therapies are most likely to work for you.
Purpose-built oncology facilities staffed by experienced specialists, from surgical theatres to image-guided radiotherapy.
A purpose-built tertiary cancer campus in Chongqing — private inpatient rooms, dedicated nurse stations and day-care lounges designed for long-stay oncology treatment.
Medical oncologists, surgical oncologists, radiation oncologists and pathologists who review every case together before treatment begins.
Answers to the questions international patients ask most before travelling.
Most patients begin with a five to seven day evaluation, during which imaging is repeated, the multidisciplinary team reviews the case and a written treatment plan is issued. Surgery usually means a two to three week stay, while radiotherapy and chemotherapy are scheduled in cycles. The case manager confirms the exact timeline in writing before flights are booked.
Yes. The international patient centre issues visa invitation letters, arranges airport pickup and hospital transfers, provides English speaking coordinators, organises medical interpretation in Arabic, Russian and other languages on request, and helps book accommodation close to the hospital.
Yes. Imaging, pathology reports and treatment history can be submitted for remote review. The multidisciplinary team returns a written opinion covering diagnosis, the treatment options available at HYGEIA and the expected care plan, so a decision can be made before committing to travel.
Send the most recent imaging on disc or film together with the written report, the pathology report, recent blood tests, a summary of treatment received so far and a list of current medicines with doses. Records in English are easiest, but scans and reports in any language can be reviewed and translated by our team.
Yes. An English speaking coordinator is assigned to every international patient, and interpretation in Arabic, Russian and other languages can be arranged for consultations, ward rounds and consent discussions. Key documents such as the treatment plan and discharge instructions are provided in English.
Yes. A companion can stay with you in the room, and single rooms are available on request. Companions are welcome to attend consultations and be present when the treatment plan is explained.
Sometimes. Where the tumour abuts but does not encase the vessels, chemotherapy and radiotherapy first can shrink it enough to allow resection, including vascular reconstruction in selected cases. This is judged from a high quality CT and team experience.
Pre operative chemotherapy is now standard for operable pancreatic cancer. It treats microscopic spread early and identifies patients whose disease is likely to progress, sparing them an operation that would not help.